Globally, the number of diabetes patients is at around half a million with over 30 million in the US alone, the most sought after market for diabetes care companies, especially those into insulin.

\"Failing organs and tissues can be revived or replaced with the help of lab-grown and 3D-printed substitutes,\" says Dr K Ravindranath, Founder and Chairman, Gleneagles Global Hospitals Group.

The food services business is expected to grow to Rs 5,52,000 crore  by 2022.

Big tech companies want to show social benefits of AI technologies